Salem Investment Counselors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-62
Closed -$15K 692
2017
Q2
$15K Buy
62
+17
+38% +$4K ﹤0.01% 434
2017
Q1
$11K Sell
45
-22
-33% -$5.12K ﹤0.01% 524
2016
Q4
$14K Buy
67
+22
+49% +$4.56K ﹤0.01% 473
2016
Q3
$104 Sell
45
-1,575
-97% -$385K ﹤0.01% 416
2016
Q2
$374K Sell
1,620
-25
-2% -$5.76K 0.04% 199
2016
Q1
$441K Sell
1,645
-80
-5% -$22.9K 0.05% 178
2015
Q4
$539K Buy
1,725
+110
+7% +$32.8K 0.07% 172
2015
Q3
$435K Sell
1,615
-1,094
-40% -$336K 0.06% 183
2015
Q2
$822K Buy
2,709
+130
+5% +$38.8K 0.1% 150
2015
Q1
$768K Buy
+2,579
New +$735K 0.09% 161

Other funds holding AGN

Salem Investment Counselors's AGN Position: Q3 2017 in Review

Salem Investment Counselors sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 62 shares — an estimated $15K sold.

Salem Investment Counselors first reported a position in AGN in Q1 2015 and held it in 10 quarters. The position peaked at $822K in Q2 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Salem Investment Counselors reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Salem Investment Counselors sold 62 Allergan plc shares in Q3 2017, an estimated $15K.
  • Salem Investment Counselors first reported a position in Allergan plc in Q1 2015 and held it in 10 quarters.
  • Salem Investment Counselors's Allergan plc position peaked at $822K in Q2 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Salem Investment Counselors's 13F filing for Q3 2017, filed 16 Nov 2017.